|
시장보고서
상품코드
2130918
비LVP 비경구 제제 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용기 유형별, 치료 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Non-LVP Parenterals Products Market Size, Share, and Growth Analysis, By Product Type (Small Volume Parenterals, Prefilled Syringes), By Container Type, By Therapeutic Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 비LVP 비경구 제제 시장 규모는 2024년에 158억 4,000만 달러로 평가되며, 2025년 169억 8,000만 달러에서 2033년까지 296억 2,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 7.2%로 성장할 것으로 전망되고 있습니다.
전 세계 비LVP(저용량 제제) 주사제 시장은 주로 급성기 치료, 외과수술 및 만성질환 관리를 목적으로 하는 항생제, 항암제, 생물제제 등 소용량 범위의 무균 주사제에 힘입어 현저한 성장을 달성하고 있습니다. 무균 가공 기술 및 첨단 제조 기술의 발전으로 확장성이 향상되어, 면역요법용 주사기 등 편의성이 높은 투여 방법의 도입이 가능해졌습니다. 또한 개인의 유전자 프로파일에 맞춘 정밀한 소용량 제제가 필요한 맞춤형 헬스케어로의 추세가 시장 역학에 큰 영향을 미치고 있습니다. 각 제조사들은 신속한 변경을 가능하게 하기 위해 유연한 무균 생산 라인을 점점 더 많이 도입하고 있으며, 이를 통해 시장 출시까지의 시간을 단축하고 폐기물을 최소화하고 있습니다. 이러한 적응성은 신흥 경제국에서 특히 유리하며, 전문적인 치료에 대한 접근성을 향상시켜 시장 확장을 더욱 촉진하고 있습니다.
전 세계 비-LVP 비경구 제제 시장의 성장 요인
생물제제를 이용한 치료에 대한 관심이 높아짐에 따라 특수 투여 시스템에 대한 수요가 급증하고 있으며, 비LVP 비경구 제제는 민감한 분자에 필요한 무균성과 안정성을 제공하고 있습니다. 이러한 증가하는 수요에 따라 제약사들은 생산 능력 강화와 임상 요건에 부합하는 혁신적인 제품 개발을 촉진하고 있으며, 치료 용도의 확대와 환자 안전성 향상을 통해 시장 확대에 기여하고 있습니다. 또한 이러한 제제가 현재의 주입 기기와 호환된다는 점은 의료 현장에서의 도입을 용이하게 하여 임상의들이 이러한 솔루션을 선호하게 만드는 한편, 공급망에 대한 투자도 강화되고 있으며, 이 모든 요소가 결합되어 시장 성장을 지원하고 있습니다.
전 세계 비-LVP 비경구 제제 시장의 제약 요인
비-LVP 기준을 충족하는 무균 제조 환경을 구축하고 유지하기 위해서는 클린룸 시설, 첨단 여과 시스템 및 지속적인 모니터링 기술에 대한 막대한 설비 투자가 필요합니다. 이러한 인프라와 관련된 비용은 전체 생산 비용을 상승시킬 가능성이 있으며, 중소기업의 시장 진입을 저해하고 가격 경쟁력을 저하시키는 요인이 됩니다. 이러한 재정적 부담은 예산 측면을 중시하고 비용 대비 효과가 높은 치료 대안을 추구하는 의료 시스템에서 비LVP 비경구 제제의 보급을 저해할 가능성이 있습니다. 또한 이러한 복잡한 공정을 관리·검증할 숙련된 인력이 필요하므로 운영 비용이 증가하고, 시장 신속 진입을 저해하는 또 다른 재정적 장벽이 발생하고 있습니다.
전 세계 비-LVP 비경구 제제 시장의 동향
전 세계 비LVP 비경구 제제 시장은 맞춤형 치료로의 뚜렷한 추세와 함께 진화하고 있으며, 환자 개개인에 맞춘 비경구 제제에 대한 수요가 증가하고 있습니다. 각 제약사는 유전체학 및 바이오마커 발견의 진전을 활용하여 개별 환자의 요구에 부응하는 정밀한 투여법을 개발하고 있습니다. 또한 유연한 생산 능력 향상으로 소량 생산이 가능해져, 높은 무균 기준을 확보하면서도 신속한 혁신을 실현하고 있습니다. 이러한 추세는 생명공학 기업과 위탁 제조 기관(CMO) 간의 전략적 제휴를 촉진하고 있으며, 궁극적으로 다양한 치료 분야에서 틈새 제품의 도입을 가속화하고 있습니다. 그 결과, 맞춤형 의료의 노력에 힘입어 시장은 상당한 성장이 예상됩니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 비LVP 비경구 제제 시장 규모 : 제품 유형별
세계의 비LVP 비경구 제제 시장 규모 : 용기 유형별
세계의 비LVP 비경구 제제 시장 규모 : 치료 용도별
세계의 비LVP 비경구 제제 시장 규모 : 최종사용자별
세계의 비LVP 비경구 제제 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.09.22Global Non-Lvp Parenterals Products Market size was valued at USD 15.84 Billion in 2024 and is poised to grow from USD 16.98 Billion in 2025 to USD 29.62 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
The market for global non-LVP parenteral products is witnessing notable growth, primarily driven by sterile injectables in small dosage ranges, including antibiotics, oncology agents, and biologics designed for acute care, surgical operations, and chronic disease management. The evolution of aseptic processing and advanced manufacturing technologies has enhanced scalability, enabling the introduction of convenient delivery methods, such as syringes for immunotherapy. Additionally, the trend towards personalized healthcare, which demands precise low-volume formulations tailored to individual genetic profiles, is significantly impacting market dynamics. Manufacturers are increasingly adopting flexible aseptic production lines to facilitate rapid changes, thus reducing time-to-market and minimizing waste. This adaptability is particularly advantageous in emerging economies, enhancing access to specialized therapies and further propelling market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Lvp Parenterals Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Non-Lvp Parenterals Products Market Segments Analysis
Global non-lvp parenterals products market is segmented by product type, container type, therapeutic application, end user and region. Based on product type, the market is segmented into small volume parenterals (SVPs), prefilled syringes, cartridges and injectable lyophilized products. Based on container type, the market is segmented into vials, ampoules, prefilled syringes and cartridges. Based on therapeutic application, the market is segmented into anti-infectives, oncology, cardiovascular disorders, endocrine disorders, pain management and others. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics and home healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Non-Lvp Parenterals Products Market
The increasing focus on biologic therapies has driven a surge in demand for specialized delivery systems, with non-LVP parenterals offering the necessary sterility and stability for sensitive molecules. This growing need encourages pharmaceutical manufacturers to enhance their production capabilities and develop innovative products that align with clinical requirements, thus contributing to market expansion through a wider range of therapeutic applications and improved patient safety outcomes. Furthermore, the compatibility of these formulations with current infusion devices facilitates their adoption in healthcare environments, leading clinicians to favor such solutions while reinforcing supply chain investments, which collectively propel market growth.
Restraints in the Global Non-Lvp Parenterals Products Market
Establishing and sustaining aseptic manufacturing environments that meet non-LVP standards entails significant capital investment in cleanroom facilities, advanced filtration systems, and continuous monitoring technology. The costs associated with these infrastructures can elevate overall production expenses, discouraging smaller companies from entering the market and reducing price competitiveness. This financial burden can hinder the wider adoption of non-LVP parenteral products within healthcare systems that prioritize budget considerations and seek cost-effective treatment alternatives. Furthermore, the requirement for skilled personnel to manage and validate these intricate processes adds to operational costs, creating additional financial obstacles that restrict swift market penetration.
Market Trends of the Global Non-Lvp Parenterals Products Market
The Global Non-LVP Parenterals Products market is evolving with a notable trend towards personalized therapy, leading to an increased demand for tailored parenteral formulations. Manufacturers are leveraging advancements in genomics and biomarker discovery to develop precise dosing methods that cater to individual patient needs. Additionally, the rise of flexible production capabilities supports small-batch manufacturing, ensuring high sterility standards while enabling rapid innovation. This trend is fostering strategic partnerships between biotechnology firms and contract manufacturing organizations, ultimately expediting the introduction of niche products across various therapeutic areas. As a result, the market is poised for significant growth driven by personalized medicine initiatives.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Non-LVP Parenterals Products Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Small Volume Parenterals (SVPs)
- Prefilled Syringes
- Cartridges
- Injectable Lyophilized Products
Global Non-LVP Parenterals Products Market Size by Container Type & CAGR (2026-2033)
- Market Overview
- Vials
- Ampoules
- Prefilled Syringes
- Cartridges
Global Non-LVP Parenterals Products Market Size by Therapeutic Application & CAGR (2026-2033)
- Market Overview
- Anti-Infectives
- Oncology
- Cardiovascular Disorders
- Endocrine Disorders
- Pain Management
- Others
Global Non-LVP Parenterals Products Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Home Healthcare
Global Non-LVP Parenterals Products Market Size & CAGR (2026-2033)
- North America (Product Type, Container Type, Therapeutic Application, End User)
- US
- Canada
- Europe (Product Type, Container Type, Therapeutic Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Container Type, Therapeutic Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Container Type, Therapeutic Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Container Type, Therapeutic Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Otsuka Holdings Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nipro Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amneal Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kedrion S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Octapharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kelun Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JW Life Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beximco Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aurobindo Pharma Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gland Pharma Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amanta Healthcare Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
